A MULITCENTER, DOUBLE-BLIND, PILOT STUDY OF MINOCYCLINE AND CREATINE IN SUBJ

米诺环素和肌酸在 SUBJ 中的多中心、双盲试点研究

• 批准号: 7375621
• 负责人: JOHN FANG
• 金额: $ 0.08万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7375621
• 关键词: MULITCENTER; DOUBLE; BLIND; PILOT; STUDY

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Specific aims: to determine whether minocycline will drecrease the number of PD subjects who clinically worsen over a two-year period, compared to placebo. to determine whether creatine will drcrease the number of PD subjects who clinically worsen over a two - year period, compared to placebo.

该子项目是利用 NIH/NCRR 资助的中心拨款提供的资源的众多研究子项目之一。子项目和研究者 (PI) 可能已从另一个 NIH 来源获得主要资金，因此可以在其他 CRISP 条目中得到体现。列出的机构是中心的机构，不一定是研究者的机构。具体目标：确定与安慰剂相比，米诺环素是否会减少两年内临床恶化的帕金森病受试者数量。确定与安慰剂相比，肌酸是否会减少两年内临床恶化的帕金森病受试者的数量。